Volume 19 Number 8
October 2023

Volume 19 Number 8

In this month’s issue, we start with an EAPCI consensus statement on transcatheter interventions for left-sided valvular heart disease complicated by cardiogenic shock; a description of the design and rationale of the DEDICATE Trial comparing the efficacy and safety of TAVI compared to SAVR in low- to intermediate-risk patients; minimally invasive beating-heart tricuspid valve surgery versus transcatheter edge-to-edge repair; the first-in-human experiences with the VDyne valve, a novel transcatheter tricuspid valve replacement prothesis; optimal treatment of coronary bifurcation lesions; Orsiro vs COMBO sirolimus-eluting stents: the SORT OUT X trial; pulmonary artery denervation in patients with Group 1 pulmonary arterial hypertension; contrast retention grading for stroke risk stratification; optical coherence tomography to visualise the endothelialisation of left atrial appendage occluders; viewpoints on aspirin bridging and the importance of the peer review; and more...

EAPCI Column

EAPCI Column
EAPCI Community news
October 23, 2023

Interventions for valvular disease and heart failure